Among the 55 astrocytoma IDH wt tumors, all five IDH wt, WHO grade II tumors had mutations that altered telomere function, including four that had TERT promoter (pTERT) mutations, and one that had an ATRX truncating mutation. Here, TERT is linked to astrocytoma (excluding glioblastoma).